Open AccessAbstract 2893: ALK amplification and rearrangements are recurrent targetable events in glioblastoma
Author(s) -
Anne-Florence Blandin
Publication year - 2019
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2019-2893
Subject(s) - crizotinib , anaplastic lymphoma kinase , cancer research , biology , immunohistochemistry , alk inhibitor , exon , microbiology and biotechnology , medicine , lung cancer , gene , pathology , genetics , immunology , malignant pleural effusion